Studies Show Early Promise Of MannKind's Cancer Immunotherapy Program In Melanoma, Prostate Cancer And Other Solid Malignancies
Medical News Today (Free subscription) | 11/02/2009
Melanoma / Skin Cancer NewsStudies Show Early Promise Of MannKind's Cancer Immunotherapy Program In Melanoma, Prostate Cancer And Other Solid MalignanciesAlso Included In: ; Article Date: 02 Nov 2009 - 4:00 PST2 (1 votes)Results of two phase 1 studies demonstrate that the novel, investigational vaccines MKC1106-MT and MKC1106-PP are well-tolerated and show encouraging immune response...



